Cargando…
1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection
The outbreak of SARS-CoV-2 virus caused more than 80,155,187 confirmed COVID-19 cases worldwide, which has posed a serious threat to global public health and the economy. The development of vaccines and discovery of novel drugs for COVID-19 are urgently needed. Although the FDA-approved SARS-CoV-2 v...
Autores principales: | Chen, Rui Hong, Yang, Li Jun, Hamdoun, Sami, Chung, Sookja Kim, Lam, Christopher Wai-kei, Zhang, Kai Xi, Guo, Xiaoling, Xia, Chenglai, Law, Betty Yuen Kwan, Wong, Vincent Kam Wai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058605/ https://www.ncbi.nlm.nih.gov/pubmed/33897423 http://dx.doi.org/10.3389/fphar.2021.634176 |
Ejemplares similares
-
Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding
por: Yang, Li Jun, et al.
Publicado: (2021) -
1,2,3,4,6-Pentagalloyl glucose of Pistacia lentiscus can inhibit the replication and transcription processes and viral pathogenesis of SARS-COV-2
por: Samandar, Farzaneh, et al.
Publicado: (2022) -
Investigation of the inhibition effect of 1,2,3,4,6-pentagalloyl-β-D-glucose on gastric cancer cells based on a network pharmacology approach and experimental validation
por: Bi, Jing-hui, et al.
Publicado: (2022) -
Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex
por: Ching, Wai-Yim, et al.
Publicado: (2022) -
Entropic contribution of ACE2 glycans to RBD binding
por: Mugnai, Mauro L., et al.
Publicado: (2023)